Shenzhen Neptunus Bioengineering Co., Ltd.
|
32.3 Billion CNY
|
90.028%
|
Anhui Fengyuan Pharmaceutical Co., Ltd.
|
4.39 Billion CNY
|
26.641%
|
Dong-E-E-Jiao Co.,Ltd.
|
13.3 Billion CNY
|
75.79%
|
Livzon Pharmaceutical Group Inc.
|
25.04 Billion CNY
|
87.137%
|
Hainan Haiyao Co., Ltd.
|
7.36 Billion CNY
|
56.269%
|
Tus-Pharmaceutical Group Co., Ltd.
|
1.15 Billion CNY
|
-179.852%
|
Jilin Aodong Pharmaceutical Group Co., Ltd.
|
32.26 Billion CNY
|
90.016%
|
Changchun High-Tech Industries (Group) Inc.
|
30.74 Billion CNY
|
89.522%
|
Apeloa Pharmaceutical Co.,Ltd
|
12.76 Billion CNY
|
74.769%
|
PKU HealthCare Corp.,Ltd.
|
2.43 Billion CNY
|
-32.119%
|
Chengdu Huasun Technology Group Inc., Ltd.
|
2.13 Billion CNY
|
-50.995%
|
Dezhan Healthcare Company Limited
|
5.37 Billion CNY
|
40.106%
|
Jinling Pharmaceutical Company Limited
|
4.55 Billion CNY
|
29.207%
|
Jiuzhitang Co., Ltd.
|
5.32 Billion CNY
|
39.558%
|
Huapont Life Sciences Co., Ltd.
|
30.72 Billion CNY
|
89.516%
|
Zhejiang Jingxin Pharmaceutical Co., Ltd.
|
7.98 Billion CNY
|
59.664%
|
Shandong Wohua Pharmaceutical Co., Ltd.
|
1.14 Billion CNY
|
-181.421%
|
Hengkang Medical Group Co., Ltd.
|
6.08 Billion CNY
|
47.018%
|
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
|
6.45 Billion CNY
|
50.121%
|
Qianjiang Yongan Pharmaceutical Co., Ltd.
|
2.34 Billion CNY
|
-37.25%
|
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
|
19.2 Billion CNY
|
83.225%
|
Jinhe Biotechnology CO., LTD.
|
5.45 Billion CNY
|
40.932%
|
Teyi Pharmaceutical Group Co.,Ltd
|
2.51 Billion CNY
|
-28.21%
|
Kunming Longjin Pharmaceutical Co., Ltd.
|
631.63 Million CNY
|
-410.017%
|
Beijing Aosaikang Pharmaceutical Co., Ltd.
|
3.52 Billion CNY
|
8.583%
|
Chengdu Kanghong Pharmaceutical Group Co., Ltd
|
8.52 Billion CNY
|
62.233%
|
Anhui Huangshan Capsule Co., Ltd.
|
1.1 Billion CNY
|
-192.039%
|
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
|
2.12 Billion CNY
|
-51.596%
|
Zhuhai Rundu Pharmaceutical Co., Ltd.
|
2.22 Billion CNY
|
-44.604%
|
Huaren Pharmaceutical Co., Ltd.
|
5.16 Billion CNY
|
37.638%
|
Tianjin Ringpu Bio-Technology Co.,Ltd.
|
6.59 Billion CNY
|
51.16%
|
Shanxi Zhendong Pharmaceutical Co.,Ltd
|
6.18 Billion CNY
|
47.877%
|
Fuan Pharmaceutical (Group) Co., Ltd.
|
5.97 Billion CNY
|
46.093%
|
Hybio Pharmaceutical Co., Ltd.
|
3.27 Billion CNY
|
1.701%
|
Baotou Dongbao Bio-Tech Co.,Ltd
|
2.74 Billion CNY
|
-17.485%
|
Hunan Er-Kang Pharmaceutical Co., Ltd
|
5.47 Billion CNY
|
41.205%
|
Changjiang Pharmaceutical Group Co., Ltd.
|
3.44 Billion CNY
|
6.51%
|
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
|
5.26 Billion CNY
|
38.763%
|
Fujian Cosunter Pharmaceutical Co., Ltd.
|
1.61 Billion CNY
|
-99.534%
|
Beijing Science Sun Pharmaceutical Co., Ltd.
|
3.62 Billion CNY
|
11.064%
|
Zhejiang Xinguang Pharmaceutical Co., Ltd.
|
930.4 Million CNY
|
-246.24%
|
Hainan Poly Pharm. Co., Ltd
|
6.28 Billion CNY
|
48.758%
|
Wuhan Hiteck Biological Pharma Co.,Ltd
|
2.97 Billion CNY
|
-8.42%
|
Shandong Xinhua Pharmaceutical Company Limited
|
8.35 Billion CNY
|
61.44%
|
Zhejiang Tianyu Pharmaceutical Co., Ltd.
|
6.33 Billion CNY
|
49.174%
|
PharmaBlock Sciences (Nanjing), Inc.
|
5.1 Billion CNY
|
36.884%
|
Jinghua Pharmaceutical Group Co., Ltd.
|
3.18 Billion CNY
|
-1.144%
|
Zhejiang Hisoar Pharmaceutical Co., Ltd.
|
7.52 Billion CNY
|
57.162%
|
Betta Pharmaceuticals Co., Ltd.
|
9.14 Billion CNY
|
64.781%
|
Tibet AIM Pharm. Inc.
|
927.74 Million CNY
|
-247.234%
|
Shenzhen Kangtai Biological Products Co., Ltd.
|
15.08 Billion CNY
|
78.645%
|
Shandong Shanda Wit Science and Technology Co., Ltd.
|
5.19 Billion CNY
|
38.029%
|
Pacific Shuanglin Bio-pharmacy Co., LTD
|
8.63 Billion CNY
|
62.674%
|
Zhejiang AngLiKang Pharmaceutical CO.,LTD.
|
3.01 Billion CNY
|
-6.671%
|
Xiamen Kingdomway Group Company
|
5.35 Billion CNY
|
39.824%
|
ShanXi C&Y Pharmaceutical Group Co., Ltd.
|
1.43 Billion CNY
|
-124.792%
|
Walvax Biotechnology Co., Ltd.
|
15.58 Billion CNY
|
79.335%
|
Sunflower Pharmaceutical Group Co.,Ltd
|
6.88 Billion CNY
|
53.19%
|
Harbin Gloria Pharmaceuticals Co., Ltd
|
3.15 Billion CNY
|
-2.188%
|
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
|
40.14 Billion CNY
|
91.976%
|
Hunan Hansen Pharmaceutical Co., Ltd.
|
2.33 Billion CNY
|
-37.875%
|
Changzhou Qianhong Biopharma CO.,LTD
|
2.76 Billion CNY
|
-16.462%
|
Shenzhen Weiguang Biological Products Co., Ltd.
|
2.87 Billion CNY
|
-11.981%
|
Honz Pharmaceutical Co., Ltd.
|
2.16 Billion CNY
|
-48.753%
|
Northeast Pharmaceutical Group Co., Ltd.
|
15.27 Billion CNY
|
78.909%
|
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
|
4.52 Billion CNY
|
28.735%
|
Guizhou Xinbang Pharmaceutical Co., Ltd.
|
9.24 Billion CNY
|
65.155%
|
Tianjin Lisheng Pharmaceutical Co.,Ltd.
|
5.78 Billion CNY
|
44.272%
|
Zhejiang Yatai Pharmaceutical Co., Ltd.
|
1.42 Billion CNY
|
-125.374%
|
Zhejiang NHU Company Ltd.
|
39.15 Billion CNY
|
91.773%
|
ApicHope Pharmaceutical Co., Ltd
|
4.4 Billion CNY
|
26.873%
|
Shanghai Kaibao Pharmaceutical CO.,Ltd
|
4.57 Billion CNY
|
29.658%
|
Beijing SL Pharmaceutical Co., Ltd.
|
6.27 Billion CNY
|
48.685%
|
Yunnan Baiyao Group Co.,Ltd
|
53.78 Billion CNY
|
94.01%
|
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
|
1.33 Billion CNY
|
-141.008%
|
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
|
1.54 Billion CNY
|
-108.817%
|
Guangdong Lifestrong Pharmacy Co., Ltd.
|
855.53 Million CNY
|
-276.541%
|
Huadong Medicine Co., Ltd
|
33.5 Billion CNY
|
90.386%
|
Jiangsu Nhwa Pharmaceutical Co., LTD
|
7.32 Billion CNY
|
56.04%
|
Harbin Medisan Pharmaceutical Co., Ltd.
|
3.44 Billion CNY
|
6.435%
|
LanZhou Foci Pharmaceutical Co.,Ltd.
|
2.52 Billion CNY
|
-27.425%
|
Tianjin Chase Sun Pharmaceutical Co.,Ltd
|
11.83 Billion CNY
|
72.78%
|
Beijing Beilu Pharmaceutical Co., Ltd
|
2.81 Billion CNY
|
-14.259%
|
Nanjing Hicin Pharmaceutical Co., Ltd.
|
1.41 Billion CNY
|
-127.038%
|
Renhe Pharmacy Co., Ltd.
|
7.44 Billion CNY
|
56.728%
|
Chongqing Pharscin Pharmaceutical Co., Ltd.
|
1.85 Billion CNY
|
-73.995%
|
Zhejiang Xianju Pharmaceutical Co.,Ltd.
|
6.99 Billion CNY
|
53.932%
|
Luoxin Pharmaceuticals Group Stock Co., Ltd.
|
5.11 Billion CNY
|
37.049%
|
Guizhou Bailing Group Pharmaceutical Co., Ltd.
|
7.34 Billion CNY
|
56.165%
|